Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00725387 · ClinicalTrials.gov registry record

Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy

A clinical trial of Neoplasms, sponsored by Stanford University.

Completed
Registry status
214
Enrollment target
5
Study locations

NCT00725387 is a study of Neoplasms that has completed, run by Stanford University. The registered enrollment target is 214 participants, below the 1,620-participant average among 158 other Neoplasms trials with a reported enrollment target (87% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00725387, a study of Neoplasms, has completed, sponsored by Stanford University.

COMPLETED
Registry status
214 participants
Enrollment target
5
Study locations

Study Summary

Fluorine-18 Fluorodeoxyglucose (F-18 FDG) PET/CT is established as a powerful imaging tool for cancer detection and monitoring response to therapy. Sodium Fluorine-18 (F-18) was used in the 1970s for bone scanning and can be used as a skeletal tracer in current PET/CT scanners. The combined administration of F-18 and F-18 FDG in a single PET/CT scan for cancer detection was not attempted to date. We hope to learn what is the best approach for detection of cancer and thus to improve cancer treatment.

Conditions Studied

Neoplasms

Study Locations (5)

Other

  • Aalborg Hospital - Aalborg
  • Apollo Hospital - Chennai
  • Coimbra University Hospital - Coimbra
  • Pretoria Academic Hospital - Pretoria

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2007-08
Est. Completion 2019-06

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00725387

The ClinicalTrials.gov registry entry for NCT00725387 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,620-participant average among 158 other Neoplasms trials with a reported enrollment target (87% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 0 interventions.

NCT00725387 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Other, California.

Frequently Asked Questions

What is clinical trial NCT00725387 about?

NCT00725387 is a clinical study titled "Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy". Fluorine-18 Fluorodeoxyglucose (F-18 FDG) PET/CT is established as a powerful imaging tool for cancer detection and monitoring response to therapy. Sodium Fluorine-18 (F-18) was used in the 1970s for bone scanning and can be used as a skeletal tracer in current PET/CT scanners. The combined administ...

What is the current status of trial NCT00725387?

This trial is currently completed. The enrollment target is 214 participants. The study started on 2007-08. Estimated completion is 2019-06.

What conditions does trial NCT00725387 study?

This clinical trial studies the following conditions: Neoplasms.

Who is sponsoring clinical trial NCT00725387?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00725387 being conducted?

This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neoplasms

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.